Interestingly, genetic variants of two other microglial receptors, the ITAM linked activating TREM2 and the ITIM containing inhibitory Siglec-3 (CD33) have been firmly linked to an increased risk for developing AD [143, 144]. The gene discussed is CD33; the disease is Alzheimer disease.